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summary
In view of the recent discovery (Molecular Cell 6, 861–871) of a (Lys76Thr) codon change in gene pfcrt on chromosome
7 which determines in vitro chloroquine resistance in Plasmodium falciparum, we have re-examined samples taken before
treatment in our study in Zaria, Northern Nigeria (Parasitology 119, 343–348). Drug resistance was present in 5}5 cases
where the pfcrt 76Thr codon change was seen (100% positive predictive value). Drug sensitivity was found in 26}28 cases
where the change was absent (93% negative predictive value). Allele pfcrt 76Thr showed strong linkage disequilibrium
with pfmdr1 Tyr86 on chromosome 5, more complete than that between pfcrt and cg2 alleles situated between recom-
bination cross-over points on chromosome 7. Physical linkage of cg2 with pfcrt may account for linkage disequilibrium
between their alleles but in the case of genes pfmdr1 and pfcrt, on different chromosomes, it is likely that this is maintained
epistatically through the selective pressure of chloroquine.
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introduction
Resistance to chloroquine in Plasmodium falciparum
developed in South East Asia and South America
about 10 years after the introduction of the anti-
malarial in the 1950s, and reached Africa by the late
1970s (Peters, 1998). In spite of its reduced efficacy,
chloroquine is still the first-line anti-malarial drug in
most of Africa for reasons of cost, and also because
widespread partial immunity in symptomatic older
children and adults enhances the effect of the drug
(Sokhna et al. 1997; Djimde et al. 2001).
Nevertheless, resistance is having a major impact.
Emergence of chloroquine resistance in Senegal,
West Africa, over 12 years was associated with at
least a 2-fold higher risk of death from malaria in
children under 10 years old (Trape et al. 1998). In
East Africa, Kenyan children under 5 admitted to
hospital for malaria are reported to have a 33% case
fatality rate if given chloroquine treatment in
contrast to 11% for sulfadoxine-pyrimethamine,
quinine or 5-day co-trimoxazole (Zucker et al. 1996).
In P. falciparum, weaker or stronger associations
(Foote et al. 1990) are seen between chloroquine
resistance and sequence changes in an MDR type
protein, Pgh1, localized in the blood-stage parasite’s
lysosomal membrane (Cowman et al. 1991), and
specified by pfmdr1 on chromosome 5. However, the
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progeny of a genetic cross showed a link between
chloroquine resistance and a locus on chromosome 7
(Wellems et al. 1990). Su et al. (1997) linked
resistance to changes in the cg2 gene on this
chromosome, which specifies a protein of unknown
function (Wellems et al. 1998). Still the correlation
with resistance failed to reach 100%, and trans-
fection of mutated cg2 did not transfer it (Fidock et
al. 2000a). A lysine to threonine (K to T) change in
codon 76 of a new gene, pfcrt (also on chromosome
7) specifying the lysosomal transmembrane protein
PfCRT, gave a complete association with in vitro
chloroquine resistance of P. falciparum isolates from
Africa, South East Asia and South America (Fidock
et al. 2000b). Wild-type PfCRT resembles a protein
reported to facilitate the transport of organic cations
(Zhang et al. 1997) and may normally be involved in
the eﬄux of basic amino acids or short basic peptides
(Eggleson, Duffin & Goldberg, 1999) from the
lysosome.
Before the discovery of pfcrt, we (Adagu &
Warhurst, 1999) examined polymorphisms asso-
ciated with chloroquine resistance in pfmdr1 and cg2
on chromosomes 5 and 7 in samples taken before
chloroquine treatment of a group of children in
Zaria, Northern Nigeria. The Asn 86 Tyr codon
change in pfmdr1, the Gly 281 Ala mutation and the
Dd2-type j repeat of cg2, were significantly asso-
ciated, suggesting co-selection by the drug. Poly-
morphisms examined were highly predictive for
drug resistance, but associations were incomplete.
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In order to complete our earlier study, we have re-
examined our collection in Zaria for polymorphism
at codon 76 of pfcrt, determined the value of this
polymorphism in prediction of drug resistance in
this geographical location, its association with poly-
morphisms in cg2 on the same chromosome and
with polymorphisms in pfmdr1 on chromosome 5.
We find that pfcrt Thr76 on chromosome 7 is highly
predictive for chloroquine resistance, and in strong
linkage disequilibrium with pfmdr1 Tyr86 on chrom-
osome 5, more complete than the degree of pfcrt 76
linkage with cg2 alleles situated between recom-
bination cross-over points on the same chromosome.
Physical linkage of cg2 with pfcrt may account for
linkage disequilibrium between their alleles but in
the case of genes pfmdr1 and pfcrt, on different
chromosomes, it is likely that, in this geographical
location, linkage is maintained epistatically through
the selective pressure of chloroquine.
materials and methods
Parasite samples examined in this study were those
previously characterized for chloroquine resistance
associated sequence variations in pfmdr1 and cg2
genes (Adagu & Warhurst, 1999). The samples were
from Zaria, an area of North Central Nigeria located
in the Guinea Savannah belt. Malaria in this area is
holoendemic and in 1993 when the samples were
collected, 20% of infections showed resistance to
chloroquine, mainly at the RI level (Adagu et al.
1995). Symptomatic children were aged from 7
months to 11 years (mean 5–2‡3 years). Geometric
mean parasitaemia on admission was 20629}mm$,
ranging from 1000 to 55353. Samples F91, F130,
F170 and F183 (3 sensitive and 1 resistant) examined
in our previous study (Adagu & Warhurst, 1999)
were no longer available. A total of 35 samples
remained.
Professor C. Plowe kindly gave us the protocol for
a nested PCR}RFLP (Djimde et al. 2001: GenBank
accession number AF233068) for detection of the
76AAAUACA (76 LysUThr) mutation in pfcrt. Nest I
primers, 5« CCG TTA ATA ATA AAT ACA CGC
AG 3« (forward) and 5« CGG ATG TTA CAA AAC
TAT AGT TAC C 3« (reverse) and the nest II
primers, 5« TGT GCT CAT GTG TTT AAA
CTT 3« (forward) and 5« CAA AAC TAT AGT
TAC CAA TTT TG 3« (reverse) were used as
described in the protocol. The PCR mix contained
standard KCl buffer, 1–25 U Taq polymerase
(Bioline), dNTPs (200 lm each), primers (1 lm each)
and for nest I reaction a sector of glass-fibre
membrane DNA source or 1 ll of nest I product for
nest II reaction. Nest I reaction (94 °C, 30 s; 56 °C,
30 s and 60 °C, 1 min) was cycled 45 times with
initial denaturation and final extension steps of
94 °C, 3 min and 60 °C, 3 min respectively. Nest II
reaction (94 °C, 30 s; 48 °C, 30 s and 65 °C, 3 min)
was cycled 30 times with an initial denaturation and
final extension steps of 94 °C, 5 min and 65 °C,
3 min respectively. Nest II product was restricted at
50 °C with 0–5 U of Apo1 restriction enzyme fol-
lowing the manufacture’s protocol and the resulting
digest was resolved in a 2% agarose gel.
Analysis of results
The diagnostic parameters of sensitivity, specificity,
and positive and negative predictive value were
calculated as follows.
Sensitivity. Percentage of resistant outcomes cor-
rectly predicted by the positive test result.
(TP}TP›FN)‹100, (where TPflTrue Positives:
FNflFalse Negatives: TNflTrue Negatives: FP
flFalse positives).
Specificity. Percentage of sensitive outcomes cor-
rectly predicted by the negative test result
(TN}TN›FP)‹100.
Positive predictive value. Percentage of positive
tests correctly predicting a resistant outcome.
(TP}TP›FP)‹100.
Negative predictive value. Percentage of negative
tests correctly predicting a sensitive outcome.
(TN}TN›FN)‹100.
Linkage disequilibrium values were calculated by
a pairwise analysis of the loci studied using the
method described by Maynard Smith (1989) for D«,
and that of Hill & Robertson (1968) for r#. Both D«
and r# have values of –1 to ›1, and the closer they
approach to fi1 or 1, the greater the linkage
disequilibrium between loci. Prevalences were used
to estimate frequencies by assuming that the pres-
ence of a single allele in a sample is indicative of
infection with a single clone. Thus mixed alleles
were excluded from the analysis. Significance of
associations was estimated using 2 by 2 tables for v #
from the EpiInfo 6 StatCalc Program.
Associations between gene polymorphisms and
chloroquine resistance were also determined by
analysis of 2‹2 tables using StatCalc. It was not
possible to calculate all diagnostic parameters for
pre-treatment data from the paper of Djimde et al.
(2001) on the basis of information supplied for the
whole population. However, data in Table 2 and in
other parts of the text in their publication were
usable. Assuming a group of 200 patients, it can be
deduced that treatment would fail in 29 (14–5%) and
succeed in 171 (85–5%). A diagnostic comparison
table can then be drawn as follows.
The calculated sensitivity of 91–8% is reported as
92% in their table, validating the calculation.
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Table 1. Diagnostic table calculated from Djimde
et al. (2001)
MALI T76 mutant K76 wild type Total
Resistant 26–622 2–378 29
True positives False negatives
Sensitive 63–954 107–046 171
False positives True negatives
Total 90–576 109–424 200
% Sensitivity 91–8
% Specificity 62–6
% PPV 29–4
% NPV 97–8
results
The chloroquine susceptibility and the pfmdr1}cg2
profiles of the parasites have been reported elsewhere
(Adagu et al. 1995; Adagu & Warhurst, 1999). Table
2 shows the 2‹2 tables and analyses of the
association between resistance and polymorphisms.
Two samples from patients with ‘resistant’ infec-
tions are of particular concern, because they showed
neither the mutant pfcrt nor the mutant pfmdr1. One
sample (F142) was from an infection found resistant
in vitro. In view of the growing body of evidence
unequivocally linking mutant pfcrt with in vitro
chloroquine resistance, it is unlikely that this is a
correct assignment. However, Djimde et al. (2001)
have reported that parasites from 8% of failed
treatments in their study in Mali did not reveal the
pfcrt mutation in the pre-treatment sample, although
it appeared in all the recurring infections examined.
We have no valid reason to exclude this infection
from our calculations. The other (F211) recurred on
day 28 and could have been a re-infection. As
reported by Adagu & Warhurst (1999), lack of post-
treatment samples in our study did not permit PCR
analysis which could have indicated cases where
recurrences were reinfections. As argued above, we
have also included this result in the calculations. All
28 samples from chloroquine-sensitive infections
carried wild-type pfcrt codon 76 (76AAA).
Table 2. Utility of the alleles studied for predicting chloroquine resistance
Resistance
and alleles
2‹2 Table
P
Sensitivity (%)
(95% limits)
Specificity (%)
(95% limits)
PPV (%)
(95% limits)
NPV (%)
(95% limits) PPV›NPV}2RES SENS
pfcrt 76T 5 0
0–00007 71 (38–105) 100 (99–101) 100 (98–102) 93 (84–103) 96–5 (90–103)
pfcrt 76K 2 28
Cg2 281A 5 6
0–02 71 (38–105) 79 (63–94) 46 (9–82) 92 (81–102) 69 (47–91)
Cg2 281G 2 22
Cg2 jDd2 6 7
0–006 86 (60–116) 75 (60–91) 46 (9–83) 96 (77–88) 71 (49–93)
Cg2 jHb3 1 21
pfmdr1 86Y 5 1
0–0004 71 (38–105) 96 (90–103) 83 (56–111) 93 (84–103) 88 (73–104)
pfmdr1 86N 2 27
Table 3 shows the measures of linkage dis-
equilibrium in paired alleles of pfcrt, cg2 and
pfmdr1. Alleles of pfcrt and pfmdr1, on different
chromosomes, show the highest degree of linkage
disequilibrium (D«fl 1 [0–99–1–01], r#fl0–81
[0–68–0–94] Pfl0–00002). This reflects the fact that
in all cases where mutant pfcrt was seen, there was
also mutant pfmdr1, although in 1 (chloroquine-
sensitive) sample, mutant pfmdr1 was found without
mutant pfcrt. Disequilibrium between cg2 281 and
pfcrt76, both on chromosome 7, had a significantly
lower value for the more stringent r# parameter than
was seen between pfmdr1 86 and pfcrt 76 on different
chromosomes. Surprisingly, both linkage measures
between cg2 281 and cg2 j,on the same gene, were
significantly lower than those between pfmdr1 86 and
pfcrt 76.
discussion
The presence of pfcrt 76Thr predicted chloroquine
resistance in our study (100% positive predictive
value). Specificity and positive predictive value using
either of 2 loci on cg2 were significantly inferior to
those obtained using pfcrt 76 or pfmdr1 86. In their
treatment trial in endemic malaria in Mali, Djimde et
al. (2001) examined the association between chloro-
quine resistance and mutations in pfcrt and pfmdr1.
Sensitivity of the test was 92% and specificity was
63%. In the Mali study, the percentage of mutant
pfcrt test results predicting treatment failures (posi-
tive predictive value) is estimated by us as 29–4%,
whilst 98% of non-mutant test results predicted
successful treatments (negative predictive value is
98%). When pfcrt 76Thr and pfmdr1 86Tyr were
considered together, specificity increased to 78%,
but sensitivity fell from 92% to 73%. Positive pre-
dictive value improved appreciably when patients
under 10 years of age were considered separately.
Recent evidence suggests that changes in pfmdr1
taking place on a background of another deter-
minant, presumably a change in pfcrt, are important
for higher levels of chloroquine resistance. Trans-
fection of pfmdr1 mutants would only enhance
I. S. Adagu and D. C. Warhurst 222
Table 3. Association and linkage disequilibrium between paired alleles of pfcrt and cg2 on chromosome 7,
and pfmdr1 on chromosome 5
D« (95% limits) r# (95% limits) P n
Paired alleles pfcrt 76T pfcrt 76K
pfmdr1 86Y 5 1
1 (0–99–1–01) 0–81 (0–68–0–94) 0–00002 35
pfmdr1 86N 0 29
cg2 281A 5 6
1 (0–99–1–01) 0–36 (0–20–0–52) 0–001 35
cg2 281G 0 24
cg2 j Dd2 5 3
1 (0–99–1–01) 0–55 (0–37–0–73) 0–0004 30
cg2 j Hb3 0 22
Paired alleles pfmdr1 86Y pfmdr1 86N
cg2 281A 6 5
1 (0–99–1–01) 0–45 (0–29–0–62) 0–0003 35
cg2 281G 0 24
cg2 j Dd2 5 3 0–77 (0–62–0–92) 0–41 (0–23–0–59) 0–002 30
cg2 j Hb3 1 21
Paired alleles cg2 281A cg2 281G
cg2 j Dd2 7 1
0–50 (0–32–0–68) 0–41 (0–23–0–59) 0–001 30
cg2 j Hb3 4 18
chloroquine resistance in clones now known to carry
mutant pfcrt (Reed et al. 2000). Unfortunately, this
possibility has not been tested directly for codon 86
allelic forms of pfmdr1. We have shown here that
linkage disequilibrium between cg2 alleles and pfcrt,
both on chromosome 7, and even for cg2 281 and the
cg2 j repeat size polymorphism on the same gene, is
less marked in these Northern Nigerian samples
than for pfcrt with pfmdr1, on different chromo-
somes. Duraisingh et al. (2000) reported linkage
disequilibrium in Gambian samples between the
cg2 x repeat size polymorphism and pfmdr1 86 (D«fl
0–87: r#fl0–27), strikingly this was higher than the
linkage between pfmdr1 codons 86 and 184, separated
by only 296 base pairs. Duraisingh et al. (2000)
concluded that the linkage disequilibrium between
the alleles of genes pfmdr1 and cg2 indicated that
these or closely related loci are important deter-
minants of chloroquine resistance, their linkage
being maintained epistatically through selection by
chloroquine. Adagu & Warhurst (1999) had also
reported linkage between pfmdr1 86 and cg2 281 and
j polymorphisms, with the same conclusion. How-
ever, our additional linkage analysis includes both
cg2 and pfcrt, which are located approximately 10K
base pairs apart (0–6 centimorgans: Su et al. 1999) on
chromosome 7, in a 36 K base-pair sequence between
recombination cross-over points mapped in the
Hb3‹Dd2 genetic cross (Su et al. 1997). This
location suggests that any linkage disequilibrium
between their alleles is related to physical linkage
and not to epistatic factors. It is highly likely that the
linkage disequilibrium we demonstrated earlier be-
tween pfmdr1 and cg2 depends on the physical
linkage of pfcrt with cg2 and that the stronger linkage
we have now shown between pfcrt and pfmdr1 on
chromosome 5 is maintained epistatically by chloro-
quine. Selection for pfmdr1 86Tyr by chloroquine
and amodiaquine was shown in a treatment trial
(Duraisingh et al. 1997). The recent study by Djimde
et al. (2001) confirmed selection of both pfmdr1
86Tyr and pfcrt 76Thr by chloroquine treatment.
It must be emphasized that an association between
pfmdr1 and chloroquine resistance has not been
confirmed in all studies especially those from other
geographical areas (for example Sudan–Awad El
Kariem, Miles & Warhurst, 1992: Thailand–Wilson
et al. 1993). Currently it appears that West and
Central Africa (Adagu et al. 1996; Adagu &
Warhurst, 1999; Basco et al. 1995; Djimde et al.
2001; Duraisingh et al. 1997, 2000; Grobusch et al.
1998) are the main areas where an association (not
absolute and presumably depending on the presence
of mutated pfcrt) between pfmdr1 codon changes and
chloroquine resistance can reliably be demonstrated.
In Brazil too, where chloroquine resistance has been
present about 20 years longer than in Africa, pfmdr1
with altered codons is predominant (Povoa et al.
1999) and mutated pfcrt has been demonstrated in in
vitro resistant isolates (Fidock et al. 2000b).
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